Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence.

about

Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence.

Item

http://www.wikidata.org/entity/Q49887274

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Adherence to treatment recomme ...... an cancer at first recurrence.

@en

Adherence to treatment recomme ...... an cancer at first recurrence.

@nl

type

Item

label

Adherence to treatment recomme ...... an cancer at first recurrence.

@en

Adherence to treatment recomme ...... an cancer at first recurrence.

@nl

prefLabel

Adherence to treatment recomme ...... an cancer at first recurrence.

@en

Adherence to treatment recomme ...... an cancer at first recurrence.

@nl

P1476

Adherence to treatment recomme ...... an cancer at first recurrence.

@en

P2093

Alfred I Neugut

http://www.w3.org/2001/XMLSchema#string

Ana I Tergas

http://www.w3.org/2001/XMLSchema#string

Cande V Ananth

http://www.w3.org/2001/XMLSchema#string

Jason D Wright

http://www.w3.org/2001/XMLSchema#string

June Y Hou

http://www.w3.org/2001/XMLSchema#string

Miriam Champer

http://www.w3.org/2001/XMLSchema#string

William M Burke

http://www.w3.org/2001/XMLSchema#string

Yongmei Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

Development of a comorbidity index using physician claims data.

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Optimal chemotherapy treatment for women with recurrent ovarian cancer

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.

Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer.

Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.

Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.

P304

19-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2017.11.008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

Grace Clarke Hillyer

Dawn L Hershman

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29153542

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5756507

http://www.w3.org/2001/XMLSchema#string